| REVIEW ARTICLE |
|
| Year : 2022 | Volume
: 2
| Issue : 1 | Page : 6-10 |
|
|
Stereotactic Arrhythmia Radioablation (STAR)
Nanditha Sesikeran Boindala
Department of Radiation Oncology, AIG Hospitals, Hyderabad, India
Correspondence Address:
Nanditha Sesikeran Boindala
Department of Radiation Oncology, AIG Hospitals, Gachibowli, Hyderabad- 500032
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/bjoc.bjoc_12_22
|
|
|
Ventricular tachycardia(VT) is a wide complex tachyarrhythmia which could be potentially life-threatening. Standard treatment options include catheter ablation, anti-arrhythmic drugs and ICDs (Implantable cardioverter defibrillator). In patients refractory to the above treatments, limited options are available. Stereotactic arrhythmia radio-ablation (STAR) is a novel non-invasive method of ablating the arrhythmogenic substrate using high dose of highly focused radiotherapy. This technique requires a multi-disciplinary team consisting of Cardiologist, Electrophysiologist, Radiation oncologist and Radiologist to integrate pre-treatment imaging and electro-physiological data to generate a target that can be radiated. Studies show excellent control of VT, 6–12 weeks post-treatment with no major toxicities. This article attempts to provide a practical step by step approach to stereotactic arrhythmia radioablation. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
